None
Quote | ResMed Inc. (NYSE:RMD)
Last: | $189.40 |
---|---|
Change Percent: | -0.13% |
Open: | $189.59 |
Close: | $189.40 |
High: | $189.99 |
Low: | $188.06 |
Volume: | 383,824 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | ResMed Inc. (NYSE:RMD)
2024-07-03 08:44:13 ET Summary RMD's competitive advantages in the sleep domain are durable, and its underlying business remains strong. It looks attractively valued based on future growth opportunities, resilient returns on capital, and potential for multiple expansions. A ma...
2024-06-29 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | ResMed Inc. (NYSE:RMD)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RMD News Article - ResMed Announces Participation in KeyBanc's Capital Markets' Life S | whytestocks | investorshangout | 03/16/2021 7:55:58 PM |
News; $RMD ResMed ($RMD) Q1 2021 Earnings Call Transcript | whytestocks | investorshub | 10/30/2020 10:45:25 PM |
$RMD was just on Cramers MAd mONEy tonight | TheFinalCD | investorshub | 04/01/2020 10:22:32 PM |
whytestocks: $RMD must see | whytestocks | investorshangout | 03/26/2020 6:10:46 PM |
News: $RMD Why ResMed Stock Is Shooting Higher Today | whytestocks | investorshub | 10/25/2019 5:00:26 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. He...
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to increase 26.7%...